Chr. Hansen reports solid financial performance in annual results despite volatile macroeconomics

12 Oct 2022 — Danish bioscience company Chr. Hansen has closed its financial year with 9% organic growth driven mainly by volume growth. Revenue increased by 13%, amounting to approximately €1.218 billion (US$1.183 billion). “We have delivered a solid financial performance despite a volatile macroeconomic and geopolitical environment. Organic growth reached 9%, …

Chr. Hansen reports solid financial performance in annual results despite volatile macroeconomics Read More »